Page 19 Medical & Healthcare Expert Guide 2019
P. 19
19
Next Steps for the Rutherford Cancer
Centres
The company opened two further centres at the end of last year
– the Rutherford Cancer Centre North East in Northumberland
which is taking patient referrals for chemotherapy, radiotherapy
and immunotherapy, and the Rutherford Cancer Centre Thames
Valley in Reading. Proton beam therapy suites at both centres are
due to open over the next few months.
Proton Partners International is building eight Rutherford Cancer
Centres across the country over the next few years, in order to
provide a treatment centre within 90 minutes of 75% of the UK
population. A centre in Liverpool is also underway and due to
open in 2019.
Mike Moran, chief executive of Proton Partners International,
said: “I am hugely proud of all that Proton Partners has achieved
since its founding four years ago. We envisioned a centre which
felt welcoming and relaxing to patients and their families, while
offering the absolute best available oncology treatments across
the board.
“Seeing the initial response from patients within the proton
therapy suite at the centre in Newport has been brilliant for myself
and all of the staff to see – it really shows that we are doing the
right thing by bringing this innovative treatment to the UK and
making it easier for patients to access this without having to
travel abroad. I look forward to seeing what the next three years
brings, and know that we will continue to champion patient care
and wellbeing alongside our commitment to constant innovation
within oncology treatment and research.”
The Lowdown: Proton Beam Therapy
There are more than 90,000 cancer patients in the UK every
year who are treated with radical radiotherapy. Proton Partners
International believes around 10% of patients treated with radical
radiotherapy – the figure accepted at European level – could be
better treatment with proton therapy.
Proton beam therapy is a type of radiotherapy used in cancer
treatment, delivering heavily charged protons in a more targeted
manner to reduce damage to peripheral tissue and organs. It can
also help to reduce side effects.
Protons deliver the same damage to cancer cells as radiotherapy;
however, they can be controlled to stop at a defined point in the
body. Due to its precision and accuracy, research has highlighted
that proton beam therapy is particularly good for treating cancers
in children and can effectively treat hard-to-reach cancers in the
brain or near the spinal cord.
Cancer Centres
Mike Moran - CEO of Proton Partners International
For more information, please visit:
www.therutherford.com
Next Steps for the Rutherford Cancer
Centres
The company opened two further centres at the end of last year
– the Rutherford Cancer Centre North East in Northumberland
which is taking patient referrals for chemotherapy, radiotherapy
and immunotherapy, and the Rutherford Cancer Centre Thames
Valley in Reading. Proton beam therapy suites at both centres are
due to open over the next few months.
Proton Partners International is building eight Rutherford Cancer
Centres across the country over the next few years, in order to
provide a treatment centre within 90 minutes of 75% of the UK
population. A centre in Liverpool is also underway and due to
open in 2019.
Mike Moran, chief executive of Proton Partners International,
said: “I am hugely proud of all that Proton Partners has achieved
since its founding four years ago. We envisioned a centre which
felt welcoming and relaxing to patients and their families, while
offering the absolute best available oncology treatments across
the board.
“Seeing the initial response from patients within the proton
therapy suite at the centre in Newport has been brilliant for myself
and all of the staff to see – it really shows that we are doing the
right thing by bringing this innovative treatment to the UK and
making it easier for patients to access this without having to
travel abroad. I look forward to seeing what the next three years
brings, and know that we will continue to champion patient care
and wellbeing alongside our commitment to constant innovation
within oncology treatment and research.”
The Lowdown: Proton Beam Therapy
There are more than 90,000 cancer patients in the UK every
year who are treated with radical radiotherapy. Proton Partners
International believes around 10% of patients treated with radical
radiotherapy – the figure accepted at European level – could be
better treatment with proton therapy.
Proton beam therapy is a type of radiotherapy used in cancer
treatment, delivering heavily charged protons in a more targeted
manner to reduce damage to peripheral tissue and organs. It can
also help to reduce side effects.
Protons deliver the same damage to cancer cells as radiotherapy;
however, they can be controlled to stop at a defined point in the
body. Due to its precision and accuracy, research has highlighted
that proton beam therapy is particularly good for treating cancers
in children and can effectively treat hard-to-reach cancers in the
brain or near the spinal cord.
Cancer Centres
Mike Moran - CEO of Proton Partners International
For more information, please visit:
www.therutherford.com
